{"id":459,"date":"2026-11-15T07:08:30","date_gmt":"2026-11-15T07:08:30","guid":{"rendered":"https:\/\/theapnachhattisgarh.com\/?p=459"},"modified":"2026-11-15T07:08:30","modified_gmt":"2026-11-15T07:08:30","slug":"indias-first-zika-vaccine-nears-human-trials-after-cdsco-panel-review-industry-news","status":"publish","type":"post","link":"https:\/\/theapnachhattisgarh.com\/?p=459","title":{"rendered":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div id=\"parent_top_div\" style=\"margin:0 0\">\n<p>An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika is a mosquito-borne infection primarily transmitted by Aedes mosquitoes, with no vaccines currently available against the disease, according to UNICEF.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The recommendation to proceed with trials was given to Human Biologicals Institute (HBI), the human health division of IIL, by the CDSCO\u2019s Subject Expert Committee (SEC) on vaccines, according to the panel\u2019s minutes of the meeting dated November 12, reviewed by Business Standard.<small class=\"brtag\">\u00a0<\/small><\/p>\n<p><span style=\"display:block;height:1px\">\u00a0<\/span><\/p>\n<p>The recommendation came nearly two months after HBI first submitted its Phase I clinical trial protocol to the panel in September this year.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The protocol proposed a randomised, double-blind, placebo-controlled study to evaluate the safety, reactogenicity and immunogenicity of a recombinant live attenuated Zika vaccine (freeze-dried) in healthy adult volunteers aged 18 to 50 years.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>At its September meeting, the committee had noted that while the firm had completed acute-dose and repeat-dose toxicity studies, along with animal immunogenicity and challenge studies, it had not submitted the scientific rationale for selecting the dose for the Phase I study.<small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The panel had also sought statistical justification for the proposed sample size, the 3:1 randomisation ratio and the selection of cohorts based on non-clinical study findings.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>It added that HBI had submitted only a summary of the non-clinical studies rather than the complete study reports.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>\u201cIn view of the above and after detailed deliberation, the committee recommended that the firm should submit the above information for further deliberation,\u201d the SEC had stated at its September 23 meeting.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>At its November meeting, the SEC reconsidered the proposal after HBI submitted the scientific rationale for dose selection and complete non-clinical study reports covering single-dose and repeat-dose toxicity, including immunogenicity studies.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The recommendation comes two years after IIL signed a memorandum of agreement (MoA) with the Indian Council of Medical Research (ICMR) to develop India\u2019s first recombinant live attenuated Zika vaccine.<small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Under the agreement, ICMR will bear the costs of Phase I clinical trials, including expenses related to trial conduct, investigations and monitoring. The trials will be conducted at ICMR network sites across India.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The SEC\u2019s recommendation is a regulatory step towards initiating human trials. The commencement of the study will depend on subsequent regulatory permission and trial-related arrangements.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>While Zika infection is typically mild and often does not require specific treatment, it can have severe consequences for pregnant women, potentially causing microcephaly and other congenital abnormalities in infants.<small class=\"brtag\">\u00a0<\/small><\/p>\n<p>In some cases, Zika infection may also result in Guillain-Barr\u00e9 syndrome (GBS), a neurological disorder.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>India has experienced sporadic, localised outbreaks of Zika virus since its first confirmed cases in 2016. No confirmed cases of Zika-associated microcephaly or GBS have been reported in the country to date.\u00a0<\/p>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended<\/p>\n","protected":false},"author":1,"featured_media":460,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-india"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5 - aioseo.com -->\n\t<meta name=\"description\" content=\"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"The Apna Chhattisgarh\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/theapnachhattisgarh.com\/?p=459\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"The Apna Chhattisgarh -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh\" \/>\n\t\t<meta property=\"og:description\" content=\"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/theapnachhattisgarh.com\/?p=459\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-15T07:08:30+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-15T07:08:30+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh\" \/>\n\t\t<meta name=\"twitter:description\" content=\"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#blogposting\",\"name\":\"India\\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh\",\"headline\":\"India\\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News\",\"author\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/1794726104_1791688455-0197.jpg\",\"width\":1200,\"height\":628},\"datePublished\":\"2026-11-15T07:08:30+00:00\",\"dateModified\":\"2026-11-15T07:08:30+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#webpage\"},\"articleSection\":\"India\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"name\":\"India\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"position\":2,\"name\":\"India\",\"item\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#listItem\",\"name\":\"India\\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#listItem\",\"position\":3,\"name\":\"India\\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"name\":\"India\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\",\"name\":\"The Apna Chhattisgarh\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cropped-WhatsApp-Image-2026-10-24-at-10.47.40-PM.jpeg\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459\\\/#organizationLogo\",\"width\":1597,\"height\":362},\"image\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1\",\"name\":\"The Apna Chhattisgarh\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/af79d0a817c8720a95b0601916cbb419fbcc63fe5df7fc5a696773013f741e58?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"The Apna Chhattisgarh\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#webpage\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459\",\"name\":\"India\\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh\",\"description\":\"An expert committee of India\\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\\u2019s Griffith University. Zika\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/1794726104_1791688455-0197.jpg\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459\\\/#mainImage\",\"width\":1200,\"height\":628},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=459#mainImage\"},\"datePublished\":\"2026-11-15T07:08:30+00:00\",\"dateModified\":\"2026-11-15T07:08:30+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#website\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"name\":\"The Apna Chhattisgarh\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh","description":"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika","canonical_url":"https:\/\/theapnachhattisgarh.com\/?p=459","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/theapnachhattisgarh.com\/?p=459#blogposting","name":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh","headline":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News","author":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"publisher":{"@id":"https:\/\/theapnachhattisgarh.com\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg","width":1200,"height":628},"datePublished":"2026-11-15T07:08:30+00:00","dateModified":"2026-11-15T07:08:30+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=459#webpage"},"isPartOf":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=459#webpage"},"articleSection":"India"},{"@type":"BreadcrumbList","@id":"https:\/\/theapnachhattisgarh.com\/?p=459#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/#listItem","position":1,"name":"Home","item":"https:\/\/theapnachhattisgarh.com\/","nextItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","name":"India"}},{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","position":2,"name":"India","item":"https:\/\/theapnachhattisgarh.com\/?cat=21","nextItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?p=459#listItem","name":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News"},"previousItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?p=459#listItem","position":3,"name":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News","previousItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","name":"India"}}]},{"@type":"Organization","@id":"https:\/\/theapnachhattisgarh.com\/#organization","name":"The Apna Chhattisgarh","url":"https:\/\/theapnachhattisgarh.com\/","logo":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/10\/cropped-WhatsApp-Image-2026-10-24-at-10.47.40-PM.jpeg","@id":"https:\/\/theapnachhattisgarh.com\/?p=459\/#organizationLogo","width":1597,"height":362},"image":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=459\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author","url":"https:\/\/theapnachhattisgarh.com\/?author=1","name":"The Apna Chhattisgarh","image":{"@type":"ImageObject","@id":"https:\/\/theapnachhattisgarh.com\/?p=459#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/af79d0a817c8720a95b0601916cbb419fbcc63fe5df7fc5a696773013f741e58?s=96&d=mm&r=g","width":96,"height":96,"caption":"The Apna Chhattisgarh"}},{"@type":"WebPage","@id":"https:\/\/theapnachhattisgarh.com\/?p=459#webpage","url":"https:\/\/theapnachhattisgarh.com\/?p=459","name":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh","description":"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/theapnachhattisgarh.com\/#website"},"breadcrumb":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=459#breadcrumblist"},"author":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"creator":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"image":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg","@id":"https:\/\/theapnachhattisgarh.com\/?p=459\/#mainImage","width":1200,"height":628},"primaryImageOfPage":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=459#mainImage"},"datePublished":"2026-11-15T07:08:30+00:00","dateModified":"2026-11-15T07:08:30+00:00"},{"@type":"WebSite","@id":"https:\/\/theapnachhattisgarh.com\/#website","url":"https:\/\/theapnachhattisgarh.com\/","name":"The Apna Chhattisgarh","inLanguage":"en-US","publisher":{"@id":"https:\/\/theapnachhattisgarh.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"The Apna Chhattisgarh -","og:type":"article","og:title":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh","og:description":"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika","og:url":"https:\/\/theapnachhattisgarh.com\/?p=459","og:image":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg","og:image:secure_url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg","og:image:width":1200,"og:image:height":628,"article:published_time":"2026-11-15T07:08:30+00:00","article:modified_time":"2026-11-15T07:08:30+00:00","twitter:card":"summary_large_image","twitter:title":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News - The Apna Chhattisgarh","twitter:description":"An expert committee of India\u2019s apex drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), has recommended that government-affiliated drugmaker Indian Immunologicals Limited (IIL) be allowed to conduct Phase I clinical trials of the country\u2019s first vaccine for the Zika virus. The vaccine has been developed in partnership with Australia\u2019s Griffith University. Zika","twitter:image":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/theapnachhattisgarh.com\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/theapnachhattisgarh.com\/?cat=21\" title=\"India\">India<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tIndia\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/theapnachhattisgarh.com\/"},{"label":"India","link":"https:\/\/theapnachhattisgarh.com\/?cat=21"},{"label":"India\u2019s first Zika vaccine nears human trials after CDSCO panel review | Industry News","link":"https:\/\/theapnachhattisgarh.com\/?p=459"}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1794726104_1791688455-0197.jpg","_links":{"self":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts\/459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=459"}],"version-history":[{"count":0,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts\/459\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/media\/460"}],"wp:attachment":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}